Cargando…
BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis
BACKGROUND: The morbidity of thyroid carcinoma has been rising worldwide and increasing faster than any other cancer type. The most common subtype with the best prognosis is papillary thyroid cancer (PTC); however, the exact molecular pathogenesis of PTC is still not completely understood. METHODS:...
Autores principales: | Zhang, Cong, Bo, Chunrui, Guo, Lunhua, Yu, Pingyang, Miao, Susheng, Gu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916035/ https://www.ncbi.nlm.nih.gov/pubmed/31842912 http://dx.doi.org/10.1186/s12957-019-1755-9 |
Ejemplares similares
-
Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023) -
MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma
por: Gierlikowski, Wojciech, et al.
Publicado: (2021) -
A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma
por: Wang, Xian, et al.
Publicado: (2018) -
Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma
por: Liu, Heng-Wei, et al.
Publicado: (2019) -
Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
por: Mohd Yacob, Aliza, et al.
Publicado: (2022)